Some patents for therapeutic biologics have aleary expired and others will soon expire. This paves the way for biopharmaceutical companies to produce biologic generics – biosimilars and/or biobetters.

Esco VacciXcell Tide Motion bioreactors are ideal for the production of secreted biosimilars and biobetters, as the cells are entrapped within the carriers greatly reduces downstream bioprocessing of the product.